ALK and lung cancer: A study into HSPC1 inhibitor sensitivity in lung cancer cells with ALK re-arrangement showed that NQO1 expression was not associated with acquired resistance to 17-DMAG, and rather, it is the induction of the multidrug resistant protein, P-glycoprotein that confers resistance in these cells (Kim et al. 2015).